Biotechnology Biogen/Eisai’s Popular Alzheimer’s Drug Leqembi Is Seeing Slow Adoption – Here’s Why – Biogen (NASDAQ:BIIB) Read more
Biotechnology Biogen’s Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings Why Is Biogen Stock Trading Higher On Wednesday? – Biogen (NASDAQ:BIIB) Read more
Biotechnology European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer’s Drug Lecanemab Why Is Biogen Stock Falling Friday? – Biogen (NASDAQ:BIIB) Read more
Biotechnology What’s Going On With Eli Lilly And Biogen Stocks On Friday? – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Biogen’s Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers – Biogen (NASDAQ:BIIB) Read more
Biotechnology Top Stocks Not Named Nvidia You Need To Know About In 2024: Here’s What Investors Think (Wall Street Vs. Reddit) – Amazon.com (NASDAQ:AMZN), AES (NYSE:AES) Read more
Biotechnology Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says – Biogen (NASDAQ:BIIB) Read more
Biotechnology Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer’s, Shifts Focus On Newer Medicines – Biogen (NASDAQ:BIIB) Read more
